[ad_1]
A team of scientists has developed a "mix" of drugs to make cells that produce insulin in duplicate, which could help cure diabetes. Scientists believe that this invention could constitute a "revolution" in the treatment of the first and second types of diabetes.
The team at Mount Sinai Hospital in Manhattan, NY, discovered a drug called Harmine, which can stimulate pancreatic cells to produce 10 times more insulin than beta cells in the pancreas.
But when the patient takes Harmine with a combination of drugs – usually used to promote bone growth – insulin increases 40 times that of beta cells.
The treatment is still experimental and is in the early stages of testing, but scientists believe that its significant impact on insulin production could trigger a "revolution" in the treatment of type I and type II diabetes.
According to the US Center for Disease and Prevention, 30.3 million people (or 9.4% of the US population) have diabetes, according to another statistic.
The study is the culmination of several studies conducted in 2015 and 2017 that concluded that "Harmine" helps to produce new beta cells.
Without drug intervention, beta cells multiply by 0.2% per day. With "Harmine", the ratio increases to 2% and, when mixed with other drugs, up to 5% to 8%.
"We need to develop ways to deliver these drugs, especially to the beta cells of the human body," he said. "We have the treatment, but we need the best way to connect it to the beta cell you need." For the treatment ".
");
//}, 3000);
}
});
//$(window).bind('scroll & # 39;);
$ (window) .scroll (function () {
if (alreadyLoaded_facebookConnect == false) {
alreadyLoaded_facebookConnect = true;
// $ (window) .unbind (& # 39; scroll & # 39;);
// console.log ("loaded scroll");
(function (d, s, id) {
var js, fjs = d.getElementsByTagName (s)[0];
if (d.getElementById (id)) return;
js = d.createElement (s); js.id = id;
js.async = true;
js._https = true;
js.src = "http://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
// pre_loader ();
// $ (window) .unbind (& # 39; mousemove & # 39;);
// setTimeout (function () {
// $ (# boxTwitter & # 39;) .html ("Tweets by @tayyar_org");
//}, 3000);
var scriptTag = document.createElement ("script");
scriptTag.type = "text / javascript"
scriptTag.src = "http://www.tayyar.org/scripts/social.js";
scriptTag.async = true;
document.getElementsByTagName ("head")[0].appendChild (scriptTag);
(function () {
$ .getScript ("http://www.tayyar.org/scripts/social.js", function () {});
});
}
});
//$(window).load(function () {
// setTimeout (function () {
// // add the returned content to a newly created script tag
// var se = document.createElement (& # 39; script & # 39;);
// se.type = "text / javascript";
// //se.async = true;
// se.text = "setTimeout (function () {pre_loader ();}, 5000);";
// document.getElementsByTagName (& # 39; body & # 39;)[0].appendChild (se);
//}, 5000);
//});
[ad_2]
Source link
